MetLife: Vanguard discloses 64,749,341 shares (9.73%) on 13G/A
The Vanguard Group filed Amendment No. 9 to Schedule 13G reporting beneficial ownership of 64,749,341 MetLife (MET) common shares, representing 9.73% of the class as of 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 9 to Schedule 13G reporting beneficial ownership of 64,749,341 MetLife (MET) common shares, representing 9.73% of the class as of 09/30/2025.
Vanguard reports 0 shares with sole voting power and 3,353,980 with shared voting power. It has sole dispositive power over 59,193,894 shares and shared dispositive power over 5,555,447 shares. The filing identifies Vanguard as an investment adviser and certifies the holdings were acquired and are held in the ordinary course, not to change or influence control.
The filing notes that Vanguard’s clients have the right to receive dividends and sale proceeds related to the reported securities, and that no single other person’s interest exceeds 5%.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Vanguard disclose in its Schedule 13G/A for MET?
How large is Vanguard’s stake in MetLife (MET)?
What is the event date and amendment number in this filing?
Did Vanguard state an intent to influence control at MetLife?
AI-generated analysis. How Rhea-AI works. Not financial advice.